Wellington Management Group LLP Acquires 21,049 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Wellington Management Group LLP raised its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 66.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 52,561 shares of the exchange traded fund’s stock after buying an additional 21,049 shares during the quarter. Wellington Management Group LLP owned about 0.07% of SPDR S&P Biotech ETF worth $5,193,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Envestnet Portfolio Solutions Inc. bought a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter valued at about $290,000. Fifth Third Bancorp grew its holdings in SPDR S&P Biotech ETF by 3.4% during the 2nd quarter. Fifth Third Bancorp now owns 118,303 shares of the exchange traded fund’s stock valued at $10,968,000 after buying an additional 3,922 shares in the last quarter. Atria Wealth Solutions Inc. increased its stake in SPDR S&P Biotech ETF by 56.1% in the 2nd quarter. Atria Wealth Solutions Inc. now owns 16,597 shares of the exchange traded fund’s stock worth $1,539,000 after acquiring an additional 5,962 shares during the last quarter. Koa Wealth Management LLC raised its holdings in shares of SPDR S&P Biotech ETF by 2.4% during the 2nd quarter. Koa Wealth Management LLC now owns 10,084 shares of the exchange traded fund’s stock worth $935,000 after acquiring an additional 232 shares in the last quarter. Finally, SOL Capital Management CO raised its holdings in shares of SPDR S&P Biotech ETF by 0.5% during the 2nd quarter. SOL Capital Management CO now owns 31,940 shares of the exchange traded fund’s stock worth $2,961,000 after acquiring an additional 174 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

XBI stock opened at $94.76 on Tuesday. The firm has a fifty day moving average price of $98.01 and a 200 day moving average price of $97.17. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47. The firm has a market cap of $7.22 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.